These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
631 related articles for article (PubMed ID: 15248937)
1. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Claxton K; Ginnelly L; Sculpher M; Philips Z; Palmer S Health Technol Assess; 2004 Jul; 8(31):1-103, iii. PubMed ID: 15248937 [TBL] [Abstract][Full Text] [Related]
2. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314 [TBL] [Abstract][Full Text] [Related]
3. Prioritisation of health technology assessment. The PATHS model: methods and case studies. Townsend J; Buxton M; Harper G Health Technol Assess; 2003; 7(20):iii, 1-82. PubMed ID: 13678549 [TBL] [Abstract][Full Text] [Related]
4. When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. Siebert U; Rochau U; Claxton K Z Evid Fortbild Qual Gesundhwes; 2013; 107(9-10):575-84. PubMed ID: 24315327 [TBL] [Abstract][Full Text] [Related]
5. The value of value of information: best informing research design and prioritization using current methods. Eckermann S; Karnon J; Willan AR Pharmacoeconomics; 2010; 28(9):699-709. PubMed ID: 20629473 [TBL] [Abstract][Full Text] [Related]
6. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review. Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062 [TBL] [Abstract][Full Text] [Related]
7. Prioritizing investments in health technology assessment. Can we assess potential value for money? Davies L; Drummond M; Papanikolaou P Int J Technol Assess Health Care; 2000; 16(1):73-91. PubMed ID: 10815355 [TBL] [Abstract][Full Text] [Related]
8. Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development. Claxton K; Palmer S; Longworth L; Bojke L; Griffin S; McKenna C; Soares M; Spackman E; Youn J Health Technol Assess; 2012; 16(46):1-323. PubMed ID: 23177626 [TBL] [Abstract][Full Text] [Related]
9. Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force. Rothery C; Strong M; Koffijberg HE; Basu A; Ghabri S; Knies S; Murray JF; Sanders Schmidler GD; Steuten L; Fenwick E Value Health; 2020 Mar; 23(3):277-286. PubMed ID: 32197720 [TBL] [Abstract][Full Text] [Related]
10. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience. Howard S; Scott IA; Ju H; McQueen L; Scuffham PA Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873 [TBL] [Abstract][Full Text] [Related]
11. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003-13: a multimethod evaluation. Guthrie S; Bienkowska-Gibbs T; Manville C; Pollitt A; Kirtley A; Wooding S Health Technol Assess; 2015 Aug; 19(67):1-291. PubMed ID: 26307643 [TBL] [Abstract][Full Text] [Related]
12. An assessment of the impact of the NHS Health Technology Assessment Programme. Hanney S; Buxton M; Green C; Coulson D; Raftery J Health Technol Assess; 2007 Dec; 11(53):iii-iv, ix-xi, 1-180. PubMed ID: 18031652 [TBL] [Abstract][Full Text] [Related]
13. Use of value of information in UK health technology assessments. Mohiuddin S; Fenwick E; Payne K Int J Technol Assess Health Care; 2014 Dec; 30(6):553-70. PubMed ID: 25816821 [TBL] [Abstract][Full Text] [Related]
14. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure. McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762 [TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model. Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954 [TBL] [Abstract][Full Text] [Related]
16. Models and applications for measuring the impact of health research: update of a systematic review for the Health Technology Assessment programme. Raftery J; Hanney S; Greenhalgh T; Glover M; Blatch-Jones A Health Technol Assess; 2016 Oct; 20(76):1-254. PubMed ID: 27767013 [TBL] [Abstract][Full Text] [Related]
17. The role of modelling in prioritising and planning clinical trials. Chilcott J; Brennan A; Booth A; Karnon J; Tappenden P Health Technol Assess; 2003; 7(23):iii, 1-125. PubMed ID: 14499052 [TBL] [Abstract][Full Text] [Related]
18. Using the Value of Information to improve conservation decision making. Bolam FC; Grainger MJ; Mengersen KL; Stewart GB; Sutherland WJ; Runge MC; McGowan PJK Biol Rev Camb Philos Soc; 2019 Apr; 94(2):629-647. PubMed ID: 30280477 [TBL] [Abstract][Full Text] [Related]